Figure 1.
MASLD development and progression after menopause: the interplay between hormonal changes, weight gain, metabolic dysfunction, genetics, and mental health disorders. SAT: subcutaneous adipose tissue; FFAs: free fatty acids; VAT: visceral adipose tissue; HSCs: hepatic stellate cells; MASLD: metabolic dysfunction-associated steatotic liver disease; MASH: metabolic dysfunction-associated steatohepatitis; HCC: hepatocellular carcinoma.
